Nucleate’s keystone program, the Activator, is a six-month, equity-free educational program designed for academic trainee-led biotech founders. Several groundbreaking companies have emerged from the Nucleate Activator, securing millions in funding and making strides in biotech innovation, some of which are:
- NextRNA Therapeutics raised $56 million in venture capital to develop therapeutics targeting non-coding RNAs.
- Manifold Bio secured $45 million as a company focused on protein design technologies and developing biologics.
- Concerto Biosciences raised $26 million to develop microbial therapies.
- Glyphic Biotechnologies raised over $44 million and is pioneering next-generation protein sequencing technologies.
“As we celebrate our growth, we reaffirm our commitment to addressing unmet needs in the biotech landscape,” stated Soufiane Aboulhouda, Co-founder and Chairman of the Board. “This report not only reflects our achievements but marks the beginning of a broader journey.”
The organization, which expanded its reach to Washington, D.C., and Baltimore in 2021, further highlights the success of the regional Activator Program. Recent regional alumni ventures including Aptabridge Therapeutics, Prompt Diagnostics, CurveAssure, and Somnair. Post Activator program these startups have gone on to participate in the LifeBridge Health BioIncubator, the Activate Fellowship, and Rice Business Plan Competition. Together, regional alumni companies have raised over >$3 million in venture and grant funding. We are grateful for the Blackbird Labs sponsorship in helping our regional programming flourish.
As we highlight the work of our program, we invite interested candidates to join the coming 2024-2025 Activator. We welcome interested candidates (PhDs, MDs, Post-Docs, MBAs, & MS students) to apply to the Nucleate program. For more details, please reach out to baltimore@nucleate.org. Apply via the following portal by Nov. 6th, 2024 (extended from Oct. 15th). For interested industry mentors and experts who would like to get involved in our invited workshop series, please fill out our interest form.
Click to access the Nucleate Flagship 5-year report and for more information, visit nucleate.org or reach out via email at contact@nucleate.org.
Nucleate’s programs are made possible thanks to our generous sponsors:
Platinum: Eli Lilly and Company, Genentech, Pillar VC, Alnylam Pharmaceuticals, BlueYard Capital, MilliporeSigma (HQ), Blackbird Labs (Regional)
Gold: Excedr (HQ)
Silver: Biocom California, Breakout Ventures, Schrödinger, Cromatic, Sanofi, PHCbi, Molecule (HQ)
Philanthropic: Schmidt Futures, Lyda Hill Philanthropies (HQ), Whiteford Taylor & Preston LLP (Regional)
Regional Partners: Johns Hopkins Pava Center for Entrepreneurship, BioBuzz Networks, Hopstone Captial, and UM Ventures
